The molecular basis of oxidative stress-induced cell death in an immortalized retinal ganglion cell line

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 2, 2005, Pages 749-757

  Maher, Pamela ^a,b   Hanneken, Anne ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; GLUTATHIONE; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; TERT BUTYL HYDROPEROXIDE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL DEATH; CELL IMMORTALIZATION; CELL LINE; CELL PROTECTION; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; DIABETIC RETINOPATHY; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; OPTIC NERVE DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA GANGLION CELL; RETINA VEIN OCCLUSION; STIMULUS RESPONSE;

ANIMALS; APOPTOSIS; CALCIUM; CELL LINE; CELL SURVIVAL; GLUTATHIONE; HYDROGEN PEROXIDE; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; RETINAL GANGLION CELLS; TERT-BUTYLHYDROPEROXIDE;

EID: 13944282893     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0883     Document Type: Article

References (34)

1. Miller NR. Optic nerve protection, regeneration and repair in the 21st century. Am J Ophthalmol. 2001;132:811-818.
2. Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol. 1995;38:357-366.
3. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993;262:689-695.
4. Jenner P. Oxidative damage in neurodegenerative diseases. Lancet. 1994;344:796-798.
5. Tan S, Schubert D, Maher P. Oxytosis: a novel form of programmed cell death. Curr Top Med Chem. 2001;1:497-506.
6. Rubin LL. Neuronal cell death: when, why and how. Br Med Bull. 1997;53:617-631.
7. Osborne NN, Ugarte M, Chao M, et al. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol. 1999;43:S102-S128.
8. Rothman SM. The neurotoxicity of excitatory amino acids is produced by passive chloride influx. J Neurosci. 1985;5:1483-1489.
9. Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol. 1986;19:105-111.
10. Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron. 1989;2:1547-1558.
11. Castilho RF, Hansson O, Ward MW, Budd SL, Nicholls DG. Mitochondrial control of acute glutamate excitotoxicity in cultured cerebellar granule cells. J Neurosci. 1998;18:10277-10286.
12. Schinder AF, Olson EC, Spitzer NC, Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 1996;16:6125-6133.
13. Li Y, Maher P, Schubert D. Requirement for cGMP in nerve cell death caused by glutathione depletion. J Cell Biol. 1997;139:1317-1324.
14. Krishnamoorthy RR, Agarwal P, Prasanna G, et al. Characterization of a transformed rat retinal ganglion cell line. Mol Brain Res. 2001;86:1-12.
15. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods. 1989;119:203-210.
16. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969;106: 207-212.
17. Ishige K, Schubert D, Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med. 2001;30:433-446.
18. Tan S, Sagara Y, Liu Y, Maher P, Schubert D. The regulation of reactive oxygen species production during programmed cell death. J Cell Biol. 1998;141:1423-1432.
19. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol. 1983;130:1910-1917.
20. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
21. Korteum K, Geiger LK, Levin LA. Differential susceptibility of retinal ganglion cells to reactive oxygen species. Invest Ophthalmol Vis Sci. 2001;41:3176-3182.
22. Li Y, Maher P, Schubert D. A role of 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron. 1997;19:453-463.
23. Aoun P, Simpkins JW, Agarwal N. Role of PPAR-g ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells. Invest Ophthalmol Vis Sci. 2003;44:2999-3004.
24. Ishige K, Chen Q, Sagara Y, Schubert D. The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death. J Neurosci. 2001;21:6069-6076.
25. Kashii S, Takahashi M, Mandai M, et al. Protective action of dopamine against glutamate neurotoxicity in the retina. Invest Ophthalmol Vis Sci. 1994;35:685-695.
26. Koh JY, Wie MB, Gwag BJ, et al. Staurosporine-induced neuronal apoptosis. Exp Neurol. 1995;135:153-159.
27. Castagne V, Clarke PGH. Neuroprotective effects of a new glutathione peroxidase mimetic on neurons of the chick embryo's retina. J Neurosci Res. 2000;59:497-503.
28. Kowluru RA, Kennedy A. Therapeutic potential of anti-oxidants and diabetic retinopathy. Expert Opin Invest Drugs. 2001;10: 1665-1676.
29. Moreno MC, Campanelli J, Sande P, Saenz DA, Sarmiento MIK, Rosenstein RE. Retinal oxidative stress induced by high intraocular pressure. Free Rad Biol Med. 2004;37:803-812.
30. Choi DW. Excitotoxic cell death. J Neurobiol. 1992;23:1261-1276.
31. Atlante A, Calissano P, Bobba A, Giannattasio S, Marra E, Passarella S. Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett. 2001;497:1-5.
32. Sucher NJ, Lipton SA, Dreyer EB. Molecular basis of glutamate toxicity in retinal ganglion cells. Vis Res. 1997;37:3483-3493.
33. Schubert D, Piasecki D. Oxidative glutamate toxicity can be a part of the excitotoxicity cascade. J Neurosci. 2001;21:7455-7462.
34. Martin KRG, Levkovitch-Verbin H, Valenta D, Baumrind L, Pease ME, Quigley HA. Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat. Invest Ophthalmol Vis Sci. 2002;43:2236-2243.